The North America Implantable Loop Recorders Market is expected to witness market growth of 11.1% CAGR during the forecast period (2020-2026).
The implantable cardiac device continues to continuously monitor the heart, contributing to the diagnosis of chronic heart problems such as stroke and heart failure. It is possible to detect and monitor disease progression by focusing on functional and structural defects in the arteries and the heart. Early identification by implantable cardiac monitors boost demand for implantable cardiac monitors (ICMs) and provide more successful results than external cardiac monitors. This, in effect, is expected to expand the demand for implantable loop recorders.
The growth in the number of patients suffering from chronic disorders, including stroke and cardiac failure, is pushing the demand for implantable loop recorders. The implantable cardiac monitor is an innovative device that induces alertness in patients to abnormal rhythm, which may contribute to potential cardiovascular problems. According to the National Institutes of Health, heart disease is the primary cause of mortality in the United States. Of the different causes of heart failure, coronary artery disease (CAD) is the most severe and main cause of myocardial infarction (heart attack).
North America led the industry with a dominant share. This rise can be due to a number of reasons, such as increasing awareness of the advantages of different cardiac tracking products, high disposable incomes, and the presence of advanced healthcare infrastructure. In addition, the involvement of major service providers with advanced healthcare solutions is expected to accelerate the growth of the implantable loop recorder market in the area during the forecast period.
Based on Application, the market is segmented into Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope. Based on End User, the market is segmented into Hospitals, Cardiac Centers and Other End Users.Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technologies Ltd.
Scope of the Study
Market Segmentation:
By Application
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
The implantable cardiac device continues to continuously monitor the heart, contributing to the diagnosis of chronic heart problems such as stroke and heart failure. It is possible to detect and monitor disease progression by focusing on functional and structural defects in the arteries and the heart. Early identification by implantable cardiac monitors boost demand for implantable cardiac monitors (ICMs) and provide more successful results than external cardiac monitors. This, in effect, is expected to expand the demand for implantable loop recorders.
The growth in the number of patients suffering from chronic disorders, including stroke and cardiac failure, is pushing the demand for implantable loop recorders. The implantable cardiac monitor is an innovative device that induces alertness in patients to abnormal rhythm, which may contribute to potential cardiovascular problems. According to the National Institutes of Health, heart disease is the primary cause of mortality in the United States. Of the different causes of heart failure, coronary artery disease (CAD) is the most severe and main cause of myocardial infarction (heart attack).
North America led the industry with a dominant share. This rise can be due to a number of reasons, such as increasing awareness of the advantages of different cardiac tracking products, high disposable incomes, and the presence of advanced healthcare infrastructure. In addition, the involvement of major service providers with advanced healthcare solutions is expected to accelerate the growth of the implantable loop recorder market in the area during the forecast period.
Based on Application, the market is segmented into Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope. Based on End User, the market is segmented into Hospitals, Cardiac Centers and Other End Users.Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technologies Ltd.
Scope of the Study
Market Segmentation:
By Application
- Atrial fibrillation
- Cardiac Arrhythmia and
- Cardiac syncope
By End User
- Hospitals
- Cardiac Centers
- Other End Users
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Angel Medical Systems, Inc.
- Vectorious Medical Technologies Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Implantable Loop Recorders Market by Application
Chapter 4. North America Implantable Loop Recorders Market by End-user
Chapter 5. North America Implantable Loop Recorders Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Angel Medical Systems, Inc.
- Vectorious Medical Technologies Ltd.
Methodology
LOADING...
